Cornerstone Therapeutics Company
Cornerstone Therapeutics Inc. (NASDAQ: CRTX) is a specialty pharmaceutical company focused on developing, acquiring, and commercialising products for the respiratory, hospital and related specialty markets. Key elements of the Company's strategy are to focus on identifying therapeutic niches within respiratory, hospital and related specialty markets to leverage existing business and create new opportunities.
Technology:
Specific disorder-related
Industry:
Treatment range
Headquarters:
Cary, USA
Founded Date:
01.01.2000
Employees Number:
51-100
Funding Status:
Acquired/Merged
Investors Number:
1
Total Funding:
$0
Estimated Revenue:
$10-50 Mn
Last Funding Date:
15.05.2012
Last Funding Type:
EKR Therapeutics acquired by Cornerstone Therapeutics
Register and Claim Ownership